Search clinical trials for: Tapentadol (CG5503) ER

Total 788 results

University Hospitals Cleveland Medical Center
Abbott

Completed

Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression

Bipolar Disorder

United States
Forest Laboratories
Merz Pharmaceuticals GmbH

Completed

Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism

Autism

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)

Type 2 Diabetes Mellitus
Universitätsklinikum Hamburg-Eppendorf
University of Hamburg-Eppendorf; GermanVasc; University Heart Center Hamburg; BARMER...

Completed

IDOMENEO - Is Treatment Reality in Vascular Medicine Evidence-based and Follows Guideline Recommendations? A Project for Quality Development Exemplified by Peripheral Arterial Disease (PAD) (IDOMENEO)

Quality of Life | Occlusive Disease of Artery of Lower Extremity | Symptomatic Peripheral Arterial Disease

Germany
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center; National Taiwan University Hospital; Duke... and other collaborators

Terminated

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Small Cell Lung Cancer

United States, Taiwan, Germany, Belgium, United Kingdom
Cukurova University

Completed

Postoperative Pain After Using Er,Cr,YSGG Lazer Irradiation During Root Canal Treatment

Postoperative Pain
M.D. Anderson Cancer Center

Terminated

An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin

Colorectal Carcinoma

United States
University Hospital, Ghent

Completed

Treatment of Periodontitis Using Er:YAG Laser vs. Conventional Treatment Modalities

Chronic Periodontitis

Belgium
Arizona State University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study)

Rheumatoid Arthritis

United States
Matthew Neal MD
Berry Consultants; University of Pittsburgh Medical Center

Terminated

REMAP Trial for Optimizing Surgical Outcomes at UPMC (UPMCREMAP)

Aging

United States
Academy of Laser Dentistry - Gulf Laser Chapter
Damascus University

Completed

Laser-Assisted Gingival Depigmentation

Hyperpigmentation; Melanin | Laser-Induced Hyperpigmentation

Qatar
Susan P. Perrine
Icahn School of Medicine at Mount Sinai; University of Illinois at Chicago; Boston... and other collaborators

Completed

Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers

Sickle Cell Anemia | Skin Ulcers

United States
Rhodes Pharmaceuticals, L.P.

Completed

Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD (PK003)

Attention-Deficit/Hyperactivity Disorder

United States
Bayer

Completed

Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times Daily

Pain
University of Ioannina

Recruiting

The Role of VitD in Rehabilitation of Idiopathic Adolescent Scoliosis (ScoliVit)

Scoliosis; Adolescence

Greece
Tonix Pharmaceuticals, Inc.
Rho, Inc.

Completed

Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD) (UPLIFT)

Depressive Disorder | Depression | Depressive Symptoms | Depressive Disorder, Major | Depressive Episode | Depression Severe

United States
Ultragenyx Pharmaceutical Inc

Terminated

A Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets in Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy [HIBM]) Patients With Severe Ambulatory Impairment

Hereditary Inclusion Body Myopathy | GNE Myopathy | Inclusion Body Myopathy 2 | Distal Myopathy With Rimmed Vacuoles | Distal Myopathy, Nonaka Type | Quadriceps Sparing Myopathy

Canada, United States, Bulgaria
Boehringer Ingelheim
Eli Lilly and Company

Completed

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects

Healthy

Germany
Boehringer Ingelheim
Eli Lilly and Company

Completed

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects

Healthy

Germany
Frederiksberg University Hospital

Completed

Opioid Induced Gait Variability

Opioid Induced Motor Disturbances

Denmark
Impax Laboratories, LLC

Completed

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

Parkinson's Disease

United States, Canada, Estonia, Latvia, Lithuania, Romania, Ukraine, Germany, Poland, Spain
University of Cincinnati
Abbott

Withdrawn

Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients

Behavioral Symptoms | Dementia | Alzheimer's Disease

United States
Sarfez Pharmaceuticals, Inc.

Completed

A Food Effect Study of 60mg ER Torsemide

Food-drug Interaction

India
M.D. Anderson Cancer Center

Withdrawn

Prospective Trial of Metformin - Chemoprevention Role

Colorectum
West German Center of Diabetes and Health
Bionatural GmbH

Completed

Foot Cream for the Care of Dry and Cracked Skin

Diabetes Mellitus

Germany
Ultragenyx Pharmaceutical Inc

Terminated

Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)

Hereditary Inclusion Body Myopathy | GNE Myopathy | Distal Myopathy With Rimmed Vacuoles | Distal Myopathy, Nonaka Type | Quadriceps Sparing Myopathy

United States, Canada, United Kingdom, Israel, Italy, Bulgaria, France
Lindner Center of HOPE
University of Cincinnati

Completed

Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)

Binge Eating Disorder

United States
University of California, San Diego
Abbott

Completed

Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes

Bipolar Disorder

United States
Pfizer

Completed

Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult Volunteers

Healthy

Belgium
Changi General Hospital
Abbott

Completed

The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates- A Placebo Controlled Trial

Pressure Ulcer

Singapore
Chinese University of Hong Kong

Completed

Herbal Treatment for Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Hong Kong
VA Office of Research and Development
Northwestern University; University of Pittsburgh; San Francisco Veterans Affairs...

Recruiting

MetfOrmin BenefIts Lower Extremities With Intermittent Claudication (MOBILE IC)

Intermittent Claudication

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

A Study to Help People Quit Smoking.

Nicotine Dependence

United States
Radboud University Medical Center
Dutch Cancer Society

Completed

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Clear Cell Renal Cell Carcinoma

Netherlands
Gwendolyn Sowa

Completed

Effects of Metformin on Low Back Pain

Low Back Pain

United States
Reckitt Benckiser Inc.

Completed

Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers

Healthy Subjects
Supernus Pharmaceuticals, Inc.

Completed

A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)

Epilepsy

United States
James Wang
United States Department of Defense

Recruiting

Managing Chronic Tendon Pain by Metformin

Chronic Pain | Tendinopathy | Achilles Tendinopathy

United States
Laboratorios Silanes S.A. de C.V.

Completed

Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)

Healthy

Mexico
Adamas Pharmaceuticals, Inc.

Terminated

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID (ALLAY-LID-II)

Parkinson's Disease | Levodopa Induced Dyskinesia (LID)

France, Germany, Canada, United States, Spain
Boehringer Ingelheim

Completed

Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers

Healthy
Janssen Korea, Ltd., Korea

Completed

A Study to Assess the Bioequivalence of a New ULTRACET Extended Release (ER) Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition

Healthy

Korea, Republic of
Palo Alto Veterans Institute for Research
National Institute of Mental Health (NIMH)

Completed

Treatment of Mania Symptoms With Drug Therapy

Schizophrenia | Bipolar Disorder

United States
Mylan Pharmaceuticals Inc

Completed

Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg

Healthy

United States
Yuzuncu Yıl University

Completed

Er,Cr:YSGG Laser Application in Peri-implantitis

Peri-Implantitis

Turkey
National Cancer Institute (NCI)

Completed

E7389 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Mylan Pharmaceuticals Inc

Completed

Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg

Healthy

United States
M.D. Anderson Cancer Center

Terminated

Metformin in Non Small Cell Lung Cancer (NSCLC)

Lung Cancer

United States
Acorda Therapeutics

Completed

Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment

Renal Insufficiency

United States
Teva Pharmaceuticals USA

Completed

Metformin ER 750 mg Tablets, Fed

Healthy

Canada

Search clinical trials for: Tapentadol (CG5503) ER

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations